Home Amines 78584-08-4
78584-08-4,MFCD04971844
Catalog No.:AA008ME7

78584-08-4 | 4,7-Dimethyl-1,3-benzothiazol-2-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
96%
in stock  
$79.00   $55.00
- +
5g
96%
in stock  
$211.00   $148.00
- +
25g
96%
in stock  
$610.00   $427.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008ME7
Chemical Name:
4,7-Dimethyl-1,3-benzothiazol-2-amine
CAS Number:
78584-08-4
Molecular Formula:
C9H10N2S
Molecular Weight:
178.2541
MDL Number:
MFCD04971844
SMILES:
Nc1nc2c(s1)c(C)ccc2C
Properties
Computed Properties
 
Complexity:
174  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
XLogP3:
2.8  

Upstream Synthesis Route

[1]ArchivderPharmazie,2016,p.651-661

[1]Patent:DE831249,1949,,

[2]ChemicalandPharmaceuticalBulletin,1991,vol.39,#11,p.2888-2895

[3]Patent:DE831249,1951,,

[4]DRP/DRBPOrg.Chem.,

Downstream Synthesis Route
607-68-1    78584-08-4    100-36-7   
<i>N</i>4-(2-diethylamino-ethyl)-<i>N</i>2-(4,7-dimethyl-benzothiazol-2-yl)-quinazoline-2,4-diyldiamine 

[1]Patent:US2710295,1950,

78584-08-4    59870-44-9   
<i>N</i>4-(2-diethylamino-ethyl)-<i>N</i>2-(4,7-dimethyl-benzothiazol-2-yl)-quinazoline-2,4-diyldiamine 

[1]Patent:DE831249,1951,

[1]ChemicalandPharmaceuticalBulletin,1991,vol.39,p.2888-2895

[2]Patent:DE831249,1951,

[1]ChemicalandPharmaceuticalBulletin,1991,vol.39,p.2888-2895

[1]Patent:WO2016/97004,2016,A1.Locationinpatent:Page/Pagecolumn96

[2]SyntheticCommunications,1993,vol.23,p.663-670

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.

Journal: Neurobiology of disease 20060101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:78584-08-4 Molecular Formula|78584-08-4 MDL|78584-08-4 SMILES|78584-08-4 4,7-Dimethyl-1,3-benzothiazol-2-amine